Professor Cipriani’s field of expertise in research is evidence synthesis and clinical trials, with a special focus on the evaluation of treatments for conditions such as depression, bipolar disorder and schizophrenia.
It is a privilege for me to accept this new role in such a stimulating environment. While in Italy, I worked closely with other consultants, nurses and research assistants in both research and clinical projects. So this fantastic opportunity is a natural step for me. - Prof Andrea CiprianiBefore moving to Oxford three years ago, he worked for ten years at the World Health Organization (WHO) Collaborating Centre for Research and Training in Mental Health and Service Evaluation, which is based at the University of Verona in Italy.
He also collaborates with the UK National Institute for Health and Clinical Excellence and the European Medicines Agency in London.
He is currently working on a new project aimed at developing and validating a computer-based clinical decision tool to help guide clinicians, patients and carers as they decide on the right treatment for a person. The hope is that this tool will help improve clinical outcome, and ultimately reduce costs.
Professor Cipriani is also the Editor-in-Chief of Evidence Based Mental Health, which works to engage psychiatrists and psychologists – particularly younger professionals – in the challenge of basing their work on evidence, and implementing research findings into real-world clinical settings.
Professor John Geddes, Head of the Department of Psychiatry and Director of R&D at Oxford Health NHS FT, said: “It is great to have Andrea on the team. He’s a world class academic, a committed and innovative clinician, a terrific communicator (and a great musician!).
He will have a key role in delivering our vision of becoming a global centre of clinical and research excellence. We’re really looking forward to working with him!”
Professor Cipriani said: "Oxford is a very special place, and I am looking forward to contributing towards exciting research opportunities working with my colleagues across organisations to promote clinical research and translate discoveries into treatments for the benefit of patients”